Systems to produce B cells genetically modified to express selected antibodies
US-12589145-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Fred Hutchinson Cancer Center — Cross-Sectional Technologies
Fred Hutchinson Cancer Center holds 25 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Fred Hutchinson Cancer Center |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 25 |
| Recent patents in slice | 17 |
| First year | 2022 |
| Last year | 2026 |
Representative patents
Notable publications linking Fred Hutchinson Cancer Center to Cross-Sectional Technologies.
Compositions and methods for providing hematopoietic function
US-2025235488-A1 · Jul 24, 2025 · US
Methods for improving adoptive cell therapy
US-12350312-B2 · Jul 8, 2025 · US
Compositions and methods for accurately identifying mutations
US-2024417790-A1 · Dec 19, 2024 · US
Compositions and methods for accurately identifying mutations
US-2024409996-A1 · Dec 12, 2024 · US
Recent filings
Latest patents from Fred Hutchinson Cancer Center in Cross-Sectional Technologies.
Systems to produce B cells genetically modified to express selected antibodies
US-12589145-B2 · Mar 31, 2026 · US
Compositions and methods for providing hematopoietic function
US-2025235488-A1 · Jul 24, 2025 · US
Methods for improving adoptive cell therapy
US-12350312-B2 · Jul 8, 2025 · US
Compositions and methods for accurately identifying mutations
US-2024417790-A1 · Dec 19, 2024 · US
Compositions and methods for accurately identifying mutations
US-2024409996-A1 · Dec 12, 2024 · US
Related pages
Navigate to parent entity pages.